Back to search
Platelet Transfusion Refractoriness (PTR)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Platelet Transfusion Refractoriness (PTR) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Platelet Transfusion Refractoriness (PTR) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Platelet transfusion refractoriness (PTR) is a common complication in patients with hematological malignancies. It not only prolongs the duration of platelet tr…
Background: Platelets are cell fragments in the blood that help it clot. Some people get very low platelet counts during a disease or treatment. Low platelet c…
The purpose of this study is to improve the platelet level of PTR patients; Prevent and improve bleeding; Help patients to successfully through the bone marrow…
Alloimmune-mediated platelet transfusion refractoriness(PTR) was usually caused by repeated blood transfusions and pregnancy and accounts for about 20-25% of PT…